 MENLO PARK, Calif. and BOSTON, Oct. 04, 2021 GLOBE NEWSWIRE -- Adicet Bio, Inc. Nasdaq: ACET, a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the Company will present data in the form of a poster presentation at the upcoming Society for Immunotherapy of Cancer SITC 36th Annual Meeting to be held November 10-14, 2021. 